Rinkey Investments’s Medtronic MDT Stock Holding History

Rinkey Investments’s Portfolio MDT Stock Details MDT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-100	Closed	-$10K	–	156
2021 Q4	$10K	Buy	+100	New	+$11.6K	0.01%	156

Other funds holding MDT

WestEnd Advisors Charlotte, North Carolina $4.49B AUM 19.44% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Lazard Asset Management New York $60.8B AUM 22.47% 1-Year Est. Return

Rinkey Investments's MDT Position: Q1 2022 in Review

Rinkey Investments sold out of Medtronic (MDT) in Q1 2022, closing a stake of 100 shares — an estimated $10K sold.

Rinkey Investments first reported a position in MDT in Q4 2021 and held it in 1 quarter. The position peaked at $10K in Q4 2021. 2,101 funds tracked by Wall St. Rank hold MDT as of Q1 2022.

Rinkey Investments reported no remaining Medtronic position as of Q1 2022 after selling out during the quarter.
Rinkey Investments sold 100 Medtronic shares in Q1 2022, an estimated $10K.
Rinkey Investments first reported a position in Medtronic in Q4 2021 and held it in 1 quarter.
Rinkey Investments's Medtronic position peaked at $10K in Q4 2021.
2,101 funds tracked by Wall St. Rank held Medtronic as of Q1 2022.

Based on Rinkey Investments's 13F filing for Q1 2022, filed 9 May 2022.